Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment-Reference-Cited by-同舟云学术

Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment

Published:2008-08 Issue:1-2 Volume:199 Page:142-150
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Mazzanti Benedetta,Aldinucci Alessandra,Biagioli Tiziana,Barilaro Alessandro,Urbani Serena,Dal Pozzo Simone,Amato Maria Pia,Siracusa Gianfranco,Crescioli Clara,Manuelli Cinzia,Bosi A.,Saccardi Riccardo,Massacesi Luca,Ballerini Clara

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference36 articles.

1. Human mesenchymal stem cells modulate allogeneic immune cell responses;Aggarwal;Blood,2005

2. Human chemokines: an update;Baggiolini;Ann. Rev. Immunol.,1997

3. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo;Bartolomew;Exp. Hematol.,2002

4. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness;Beyth;Blood,2005

5. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogenic-stimulated lymphocytes in vitro;Bocelli-Tyndall;Rheumatology,2007

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies;Stem Cells Translational Medicine;2023-12-14

2. Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis;International Journal of Neuroscience;2022-05-17

3. Considerations for Clinical Use of Mesenchymal Stromal Cells;Handbook of Stem Cell Therapy;2022

4. Considerations for Clinical Use of Mesenchymal Stromal Cells;Handbook of Stem Cell Therapy;2022

5. Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection;Multiple Sclerosis Journal;2021-11-29